Fennec Pharmaceuticals Inc. Director Rosty Raykov Sells 10,000 Shares

On August 5, 2025, Rosty Raykov, a director of Fennec Pharmaceuticals Inc., sold 10,000 common shares at a price of $8.09 per share. This transaction was conducted pursuant to a 10b5-1 plan dated August 23, 2024. Following the sale, Raykov owns 55,878 common shares. The sale was reported in a Form 4 filing with the SEC. The transaction is notable as it involves a significant number of shares and was executed under a pre-established trading plan, which is often used to avoid concerns about insider trading.